Results 81 to 90 of about 18,331 (224)
Bengal Journal of Otolaryngology and Head Neck Surgery, 2017 Introduction A case of Langerhans cell histiocytosis (LGH) involving extensive area of base of skull resulting in panhypopituitarism and diabetes insipidus (DI) is reported.
Anirban Ghosh +2 more
doaj +3 more sources
Doença de células de langerhans e mama.
Acta Médica Portuguesa, 2011 Langerhans cell histiocytosis (LCH) is a rare systemic disorder, with a diversified presentation and natural history. It can compromise any organ. We report a case of a 32-year-old woman who came to our clinic with an asymptomatic palpable breast mass ...
Cátia Rodrigues +4 more
doaj +1 more source
Bagaimana Prognosis Histiocytosis? Sebuah Laporan Kasus [PDF]
, 2013 Penderita histiocytosis dengan keterlibatan multiorgan dan disertai gangguan fungsi organ mempunyai prognosis buruk dan tingkat mortalitas tinggi. Dilaporkan seorang penderita histiocytosis, usia 1 tahun 1 bulan yang datang dengan kelainan di kulit ...
Lestari, R. D. (Rini) +1 more
core
Building a precision therapeutics program at a tertiary care children's hospital
Pediatric Investigation, EarlyView.
Luke Hamilton +8 more
wiley +1 more source
International Journal of Cancer, Volume 158, Issue 10, Page 2674-2683, 15 May 2026.What's new? Mitogen‐activated protein kinase (MAPK) inhibitors are promising treatments for pediatric Langerhans cell histiocytosis (LCH), a rare heterogeneous neoplasm that often affects multiple organ systems. Which MAPK inhibitors are most effective against LCH remains uncertain.
Xue Tang +5 more
wiley +1 more source
Journal of Medical Case ReportsBackground Langerhans cell histiocytosis is a rare disease of the reticuloendothelial system. This report presents a novel case of Langerhans cell histiocytosis with systemic involvement that started with a simple chief complaint.
Hassan Mirmohammad Sadeghi +6 more
doaj +1 more source
Gastrointestinal Langerhans cell histiocytosis responding to cladribine and imatinib mesylate [PDF]
, 2010 Gastrointestinal involvement in Langerhans cells histiocytosis (LCH) is extremely rare. An optimal treatment regimen is not defined yet and its prognosis is relatively poor.
Agreda Vásquez, Gladys Patricia +4 more
core
Langerhans cells : sensing the environment in health and disease [PDF]
, 2018 In the last few decades, our understanding of Langerhans cells (LCs) has drastically changed based on novel findings regarding the developmental origin and biological functions of these epidermis-specific resident immune cells.
Deckers, Julie +2 more
core +2 more sources
A 50‐year‐old man with a 12‐year history of extensive pachymeningeal thickening
Brain Pathology, EarlyView.
Alyssa M. Lee +3 more
wiley +1 more source
Implementing Health‐Related Quality of Life Assessment in Pediatric Oncology: A Feasibility Study
Pediatric Blood &Cancer, Volume 73, Issue 5, May 2026.ABSTRACT Background There is growing interest in embedding health‐related quality of life (HRQoL) assessment and patient‐reported outcome measures (PROMs) within clinical cancer care. This study evaluated the feasibility, acceptability, and usability of implementing an electronic PROM (ePROM) platform to measure HRQoL in children with cancer ...
Mikaela Doig +13 more
wiley +1 more source